Victory Capital Management Inc. Takes $10.78 Million Position in Phreesia, Inc. (NYSE:PHR)

Victory Capital Management Inc. acquired a new stake in shares of Phreesia, Inc. (NYSE:PHR) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 421,820 shares of the company’s stock, valued at approximately $10,782,000. Victory Capital Management Inc. owned 0.72% of Phreesia as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in PHR. Raymond James Financial Inc. purchased a new stake in shares of Phreesia during the 4th quarter valued at $379,000. Swiss National Bank grew its stake in shares of Phreesia by 1.3% during the 4th quarter. Swiss National Bank now owns 107,900 shares of the company’s stock valued at $2,715,000 after buying an additional 1,400 shares during the period. American Century Companies Inc. purchased a new stake in shares of Phreesia during the 4th quarter valued at $644,000. Sei Investments Co. grew its stake in shares of Phreesia by 8.4% during the 4th quarter. Sei Investments Co. now owns 196,815 shares of the company’s stock valued at $4,952,000 after buying an additional 15,241 shares during the period. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of Phreesia during the 4th quarter valued at $259,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Stock Performance

Shares of PHR stock opened at $27.09 on Friday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. The firm has a market capitalization of $1.61 billion, a P/E ratio of -36.60 and a beta of 0.72. The company’s fifty day moving average price is $26.58 and its two-hundred day moving average price is $26.43.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. During the same quarter in the previous year, the business posted ($0.05) EPS. The firm’s revenue was up 14.5% compared to the same quarter last year. On average, research analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Mark Douglas Smith sold 7,000 shares of the business’s stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $29.00, for a total transaction of $203,000.00. Following the completion of the sale, the director owned 37,353 shares of the company’s stock, valued at $1,083,237. This represents a 15.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Allison C. Hoffman sold 1,245 shares of the business’s stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $33,478.05. Following the sale, the general counsel directly owned 136,978 shares of the company’s stock, valued at approximately $3,683,338.42. This represents a 0.90% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,804 shares of company stock worth $1,510,733. 5.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently issued reports on PHR shares. KeyCorp boosted their price objective on shares of Phreesia from $28.00 to $35.00 and gave the company an “overweight” rating in a research note on Monday, July 14th. Wall Street Zen upgraded shares of Phreesia from a “hold” rating to a “buy” rating in a report on Sunday, June 1st. DA Davidson upgraded shares of Phreesia to a “strong-buy” rating in a report on Tuesday. Truist Financial lifted their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, May 29th. Finally, Canaccord Genuity Group reduced their target price on shares of Phreesia from $35.00 to $34.00 and set a “buy” rating on the stock in a report on Thursday, May 29th. Eleven analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Phreesia presently has an average rating of “Buy” and a consensus price target of $32.27.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.